Description: The Cancer Biology Division at GCC Biotech develops RT-PCR-based kits to detect key biomarkers in various cancers, including lung, breast, prostate, colorectal, pancreatic, brain, oral cancers, and leukemia. Our focus is on identifying driver mutations in oncogenes such as KRAS, NRAS, BRAF, EGFR, BRCA1/2, and gene fusions like BCR-ABL and ALK-EML4. We also offer TaqMan-based RT-PCR kits to measure overexpressed genes in cancer, such as HER2, PSA, PSCA, and β2-microglobulin.